Natural History of Netherton Syndrome

Updated 05/03/2024

Status Not yet recruiting

Clinical Trial Summary

The goal of this non-interventional study (NIS) is to collect real-world data to describe the natural history of Netherton Syndrome (NS).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05902663
Study type	Observational
Source	Boehringer Ingelheim
Contact	Boehringer Ingelheim
Phone	1-800-243-0127
Email	clintriage.rdg@boehringer-ingelheim.com
Status	Not yet recruiting
Phase
Start date	May 16, 2024
Completion date	May 31, 2026

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05979831` - A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome	Phase 1/Phase 2
	Completed	`NCT00208026` - Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome	Phase 1/Phase 2
	Completed	`NCT05583669` - A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy Subjects	Phase 1
	Completed	`NCT01428297` - A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome	Phase 1
	Recruiting	`NCT05856526` - A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome	Phase 2/Phase 3
	Recruiting	`NCT05789056` - Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome	Phase 2/Phase 3
	Recruiting	`NCT05521438` - Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome	Phase 2/Phase 3
	Completed	`NCT05388903` - A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects	Phase 1
	Recruiting	`NCT04244006` - A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome	Phase 2/Phase 3
	Recruiting	`NCT03417856` - Defining the Skin and Blood Biomarkers of Ichthyosis
	Completed	`NCT02113904` - Clinical Trial Using Humira in Netherton Syndrome	Phase 2
	Not yet recruiting	`NCT06137157` - Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome	Phase 1
	Recruiting	`NCT05211830` - A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome	Phase 1/Phase 2
	Completed	`NCT03041038` - The Efficacy and Safety of Secukinumab in Patients With Ichthyoses	Phase 2
	Recruiting	`NCT01545323` - Gene Therapy for Netherton Syndrome	Phase 1
	Recruiting	`NCT02081313` - Natural History and Biological Study of Netherton Syndrome	N/A